Sign In
Buy MORF
$56.99
+0 (+0%)
At Close: Nov 14, 2024
Eli Lilly Buys Morphic for $3.2B
09:59am, Monday, 08'th Jul 2024
Eli Lilly (LLY) agreed to buy biopharmaceutical firm Morphic (MORF) at a significant premium, sending shares of Morphic skyrocketing Monday.
Eli Lilly Buys Bowel Disease Drug Developer Morphic In $3.2 Billion Deal
09:37am, Monday, 08'th Jul 2024
Eli Lilly will acquire biopharmaceutical firm Morphic Holding in a deal valued at $3.2 billion, both companies announced Monday, a transaction that includes an experimental medication for inflammatory
MORF Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Morphic Holding to Eli Lilly
09:10am, Monday, 08'th Jul 2024
MONSEY, N.Y., July 08, 2024 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating the fairness of the proposed sale of Morphic Holding, Inc. (Nasdaq: MORF) (“Morphic”) to Eli Li
Nasdaq Index, Dow Jones, S&P 500 News: Morphic Holding Shares Surge Over 75%; Alibaba Group Stumbles
08:57am, Monday, 08'th Jul 2024
Nasdaq flat, but Alibaba shares dip 1.17% pre-market as AI progress showcased at Shanghai conference.
Eli Lilly's First Biotech Deal Of 2024, Buys Chronic Disease Player Morphic For $3.2B
08:55am, Monday, 08'th Jul 2024
Monday, Eli Lilly And Co LLY agreed to acquire Morphic Holding Inc MORF for $57 per share in cash, an aggregate of approximately $3.2 billion.
Eli Lilly to acquire Morphic Therapeutics for $3.2 billion in cash
07:26am, Monday, 08'th Jul 2024
CNBC's Joe Kernen reports on the latest news.
Eli Lilly to Buy Morphic for $3.2 Billion. Morphic Stock Surges 78%.
07:24am, Monday, 08'th Jul 2024
Eli Lilly agrees to pay $57 a share for Morphic, or a 79% premium to the stock's closing price of $31.84 on Friday.
Morphic's stock rockets after $3.2 billion buyout deal with Eli Lilly
06:56am, Monday, 08'th Jul 2024
Shares of Morphic Holding Inc. MORF, +0.03% rocketed 76% in premarket trading Monday, after the biopharmaceutical company announced an agreement to be acquired by Eli Lilly & Co. LLY, +1.83% in a cash
Eli Lilly to acquire Morphic Holding for $3.2 billion
06:52am, Monday, 08'th Jul 2024
Eli Lilly will acquire Morphic Holding for $3.2 billion, the companies said on Monday.
Lilly to Acquire Morphic to Improve Outcomes for Patients with Inflammatory Bowel Disease
06:45am, Monday, 08'th Jul 2024
Acquisition to expand Lilly's immunology pipeline with oral integrin therapies INDIANAPOLIS and WALTHAM, Mass. , July 8, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Morphic Holding, In
MORF NEWS: Johnson Fistel Continues Investigation on Behalf of Morphic Holding Shareholders
12:45pm, Monday, 17'th Jun 2024
SAN DIEGO, CA / ACCESSWIRE / June 17, 2024 / Johnson Fistel, is investigating potential securities claims against Morphic Holding, Inc. (NASDAQ:MORF) on behalf of stockholders. The investigation focus
Morphic to Participate in Jefferies Global Healthcare Conference
08:00am, Friday, 31'st May 2024
WALTHAM, Mass., May 31, 2024 (GLOBE NEWSWIRE) -- Morphic Therapeutic (Nasdaq: MORF), a biotechnology company developing a new generation of oral integrin therapies for the treatment of serious chroni
Morphic Announces Corporate Highlights and Financial Results for the First Quarter 2024
07:00am, Thursday, 25'th Apr 2024
MORF ends 1Q24 with $659 million, cash into 2H27; phase 2b study of MORF-057 in UC continues on target; anticipate GARNET phase 2 in Crohn's to begin 2Q
What Makes Morphic (MORF) a New Buy Stock
01:01pm, Wednesday, 24'th Apr 2024
Morphic (MORF) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
LOS ANGELES, CA / ACCESSWIRE / April 16, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Morphic Holding,
